Raphaël De Coninck is a panelist at this conference and will speak on EU/US/Asia Merger Developments in 2017. CRA is also a sponsor.
For more information on this event, click here.
What’s 340B? An economist’s view of the recent wave of 340B litigation
But this change has led to complex relationships among pharmaceutical manufacturers, hospitals, pharmacies, and third-party administrators, increasing...
